Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Sector: Healthcare; Industry: Biotechnology

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2019-09-18 COATS LONNEL President and CEO Buy 50,000 $3.10 $155,000 No
2019-09-17 COATS LONNEL President and CEO Buy 50,000 $3.13 $156,403 No
2019-08-19 COATS LONNEL President and CEO Buy 40,000 $1.35 $54,029 No
2017-11-15 COATS LONNEL President and CEO Buy 10,000 $9.91 $99,100 No
2017-09-15 COATS LONNEL President and CEO Buy 30,000 $12.54 $376,337 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.